[1]
Bojanowski, H. et al. 2026. Effects of GLP-1 Receptor Agonists on Bone Metabolism and Fracture Risk in Type 2 Diabetes and Obesity: Mechanisms and Clinical Evidence — A Narrative Review. Journal of Education, Health and Sport. 90, (Apr. 2026), 70093. DOI:https://doi.org/10.12775/JEHS.2026.90.70093.